About Biovest
Biovest is a Healthcare company based in Minneapolis (United States) founded in 1981 by Kyriakides. Therapeutic cancer vaccine BiovaxID is developed for Non-Hodgkins Lymphoma. The company has 19 employees. Its chief executive, as recorded, is Christiaan Engstrom. Biovest offers products and services including Cell Culture Expansion, Antibody Production, Cell Banking, Perfusion Bioreactors, and Purification Services. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is Cell Culture Company, LLC. Similar companies include C4 Therapeutics, Erasca and Revolution Medicines; 3 of its 3 listed similar companies have raised funding.
Company details
Biovest International (formerly known as Cellex Biosciences; formerly a subsidiary of Accentia Biopharmaceuticals) is a biotechnology company that develops therapeutic cancer vaccines. The company develops and commercializes BiovaxID (dasiprotimut-T), a cancer vaccine whose first indication is intended to be consolidationadjuvant therapy of follicular Non-Hodgkins Lymphoma. In Jan 2014, Biovests Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) was accepted following the successful completion and long-term follow-up of two Phase 2 clinical trials and of one multi-center, randomized, Phase 3 clinical trial (all conducted in partnership with the U.S. National Cancer Institute) in which BiovaxID demonstrated it could induce powerful anti-tumor immune responses, eradicate residual tumor cells from patients blood following chemotherapy, and improve the duration of complete remissions by a median of 15.4 months relative to control. In Jan 2016, the instrument and contract manufacturing offerings of Biovest were spun-out into a wholly owned subsidiary - Cell Culture Company (C3).
- Headquarters Minneapolis, United States
- Employees 19
- Founders Kyriakides
- SectorsHealthcare
- Website biovest.com
- Social LinkedIn X Facebook
- Legal Name Cell Culture Company, Llc
- Employee Count19
Products & Services of Biovest
Biovest offers a comprehensive portfolio of products and services, including Cell Culture Expansion, Antibody Production, Cell Banking, Perfusion Bioreactors, and Purification Services.
Service for expanding mammalian and insect cells for research.
Manufacturing antibodies for diagnostic and therapeutic uses.
Secure storage and management of cell lines.
Bioreactor systems for efficient cell culture processes.
Protein purification for biotech applications.
People of Biovest
2 people are tracked at Biovest (2 in leadership); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Kyriakides | Founder | Leadership |
Christiaan Engstrom | CEO | Leadership |
Complete people profiles for Biovest
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Biovest
Biovest has 3 listed similar companies in our database, 3 of them funded. They include C4 Therapeutics, Erasca and Revolution Medicines.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. | |
| erasca.com | 2018 | San Diego, United States | $300M | 120 | Small molecule therapeutics for cancer treatment are developed. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. |
Detailed similar companies of Biovest
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biovest
Websites that share an audience with Biovest (biovest.com).
Websites whose visitors overlap most with Biovest. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cell-essentials.com | 100% | View details | |||
| unitargeting.com | 100% | View details | |||
| vitrocell.com | 100% | 1.5K | #12,693,960 | View details | |
cepower.ch | cepower.ch | 100% | – | ||
nccc.com | nccc.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Biovest
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Biovest (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biovest
Complete news archive for Biovest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biovest
Biovest was founded in 1981.
Biovest is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Christiaan Engstrom is the CEO of Biovest, as recorded in our data.
Biovest has 19 employees.
Biovest International (formerly known as Cellex Biosciences; formerly a subsidiary of Accentia Biopharmaceuticals) is a biotechnology company that develops therapeutic cancer vaccines. The company develops and commercializes BiovaxID (dasiprotimut-T), a cancer vaccine whose first indication is intended to be consolidationadjuvant therapy of follicular Non-Hodgkins Lymphoma. In Jan 2014, Biovests Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) was accepted following the successful completion and long-term follow-up of two Phase 2 clinical trials and of one multi-center, randomized, Phase 3 clinical trial (all conducted in partnership with the U.S. National Cancer Institute) in which BiovaxID demonstrated it could induce powerful anti-tumor immune responses, eradicate residual tumor cells from patients blood following chemotherapy, and improve the duration of complete remissions by a median of 15.4 months relative to control. In Jan 2016, the instrument and contract manufacturing offerings of Biovest were spun-out into a wholly owned subsidiary - Cell Culture Company (C3).
Biovest's top competitors include C4 Therapeutics, Erasca and Revolution Medicines.
Biovest offers Cell Culture Expansion, Antibody Production, Cell Banking, Perfusion Bioreactors, and Purification Services.
Biovest operates through Cell Culture Company, Llc.